CMPX

CMPX Operating Income Growth

-19.52%TTM

Period ending:

CMPX TTM Operating Income YoY %%
CMPX TTM Operating Income YoY %88.27%-243.30%
2020-09-302026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

CMPX operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 24 observations from Sep 30, 2020 to Jun 30, 2026.

Compass Therapeutics Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
-19.5151%
-21.5903%
-28.6272%
-28.8131%
-23.0547%
-15.7189%
-12.4308%
-15.8476%
-13.5987%
-20.9171%
-20.9147%
-14.5901%
-38.5735%
45.9364%
49.1286%
45.6372%
56.1866%
-178.7381%
-194.4161%
-192.5373%
-211.2162%
-0.1058%
18.3249%
5.0127%

Compare operating income growth

All CMPX financial metrics · CMPX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.